This new information suggests that serous ovarian cancer may arise in an epithelium that normally expresses CLDN3 and CLDN4 and supports the concept that those cancers that continue to express these proteins are less aggressive than those in which their expression is lost mimicking what is known about “high” versus “low” claudin breast cancers. Here, CLDN3 is linked to ovarian serous adenocarcinoma.